Factors associated with hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma

被引：0
|
作者：
Hoekstra, N. [1 ]
Van Linge, A. [2 ]
Wolbers, J. [3 ]
Van Os, R. [4 ]
Stienstra, L. [1 ]
Dallenga, A. [3 ]
Heijmen, B. [1 ]
Romero, A. Mendez [1 ]
机构：
[1] Erasmus MC Canc Inst, Radiotherapy, Rotterdam, Netherlands
[2] Erasmus MC, Otorhinolaryngol & Head & Neck Surg, Rotterdam, Netherlands
[3] Erasmus MC, Neurosurg, Rotterdam, Netherlands
[4] Acad Med Ctr, Radiotherapy, Amsterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0769
引用
收藏
页码：S47 / S48
页数：2
相关论文
共 50 条
  • [1] Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
    A. van Linge
    R. van Os
    N. Hoekstra
    B. Heijmen
    L. Stienstra
    A. Dallenga
    J. Wolbers
    A. Mendez Romero
    Radiation Oncology, 13
  • [2] Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level
    van Linge, A.
    van Os, R.
    Hoekstra, N.
    Heijmen, B.
    Stienstra, L.
    Dallenga, A.
    Wolbers, J.
    Romero, A. Mendez
    RADIATION ONCOLOGY, 2018, 13
  • [3] Hearing preservation after LINAC radiosurgery and LINAC radiotherapy for vestibular schwannoma
    Fong, Brendan M.
    Pezeshkian, Patrick
    Nagasawa, Daniel T.
    De Salles, Antonio
    Gopen, Quinton
    Yang, Isaac
    JOURNAL OF CLINICAL NEUROSCIENCE, 2012, 19 (08) : 1065 - 1070
  • [4] Medication for hearing loss after fractionated stereotactic radiotherapy (SRT) for vestibular schwannoma
    Sakamoto, T
    Shirato, H
    Takeichi, N
    Aoyama, H
    Kagei, K
    Nishioka, T
    Fukuda, S
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 50 (05): : 1295 - 1298
  • [5] LINAC-based stereotactic Radiosurgery and fractionated stereotactic Radiotherapy in the Treatment of vestibular Schwannomas
    Badakhshi, H.
    Muellner, S.
    Boehmer, D.
    Budach, V
    STRAHLENTHERAPIE UND ONKOLOGIE, 2011, 187 : 75 - 75
  • [6] SINGLE FRACTION VERSUS FRACTIONATED LINAC-BASED STEREOTACTIC RADIOTHERAPY FOR VESTIBULAR SCHWANNOMA: A SINGLE-INSTITUTION EXPERIENCE
    Collen, Christine
    Ampe, Ben
    Gevaert, Thierry
    Moens, Maarten
    Linthout, Nadine
    De Ridder, Mark
    Verellen, Dirk
    D'Haens, Jean
    Storme, Guy
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : E503 - E509
  • [7] Linac-based stereotactic radiosurgery and radiotherapy
    Ayadi, M.
    Ginestet, C.
    Gassa, F.
    Claude, L.
    Mazeron, J. -J.
    BULLETIN DU CANCER, 2010, 97 (07) : 791 - 806
  • [8] Planning issues on linac-based stereotactic radiotherapy
    Yang-Yang Huang
    Jun Yang
    Yi-Bao Liu
    World Journal of Clinical Cases, 2022, (35) : 12822 - 12836
  • [9] Planning issues on linac-based stereotactic radiotherapy
    Huang, Yang-Yang
    Yang, Jun
    Liu, Yi-Bao
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (35) : 12822 - 12836
  • [10] Normal tissue reactions after linac-based radiosurgery and stereotactic radiotherapy
    Gross, MW
    Engenhart-Cabillic, R
    NORMAL TISSUE REACTIONS IN RADIOTHERAPY AND ONCOLOGY, 2002, 37 : 140 - 150
12345